Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

CAUSSADE

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
International Review of Psychiatry (Abingdon, England)|April 21, 2012
Demographics and treatment of the American familyMirjana Jojic, Abita Raj, Kerry Wilkins, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistF Caussade, A Virone-Oddos, C Delchambre, et al.
Contact Dermatitis|March 1, 1996
Allergic contact dermatitis from mesnaK Benyoussef, A Bottlaender, H R Pfister, et al.
Revista Medica De Chile|September 29, 2025
[Dupilumab for the Management of Moderate-to-Severe Atopic Dermatitis in Pediatric Patients in Chile: A Series of 10 Clinical Cases]Ignacia Fuentes Escobar, Marie-Chantal Caussade, Cristóbal Lecaros Cornejo, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 14, 2010
Bronchial hyperreactivity to methacholine in atopic versus nonatopic asthmatic schoolchildren and preschoolersJose A Castro-Rodriguez, Pamela Navarrete-Contreras, Linus Holmgren, et al.
British Journal of Pharmacology|February 1, 1997
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferationA Virone-Oddos, V Desangle, D Provost, et al.
Archives of Dermatological Research|January 1, 1985
Normal peripheral-blood lymphocyte cAMP and cGMP resting levels in untreated patients with mycosis fungoidesA Aleksijevic, P Caussade, J M Lang, et al.
Pediatric Pulmonology|September 2, 2003
Risk factors for recurrent wheezing following acute bronchiolitis: a 12-month follow-upLorena Cifuentes, Solange Caussade, Claudia Villagrán, et al.
Journal of Neural Engineering|December 15, 2023
Towards a more accurate quasi-static approximation of the electric potential for neurostimulation with kilohertz-frequency sources<sup></sup>Thomas Caussade, Esteban Paduro, Matías Courdurier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998
Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?C Courteix, P Bourget, F Caussade, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
International Review of Psychiatry (Abingdon, England)|April 21, 2012
Demographics and treatment of the American familyMirjana Jojic, Abita Raj, Kerry Wilkins, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonistF Caussade, A Virone-Oddos, C Delchambre, et al.
Contact Dermatitis|March 1, 1996
Allergic contact dermatitis from mesnaK Benyoussef, A Bottlaender, H R Pfister, et al.
Revista Medica De Chile|September 29, 2025
[Dupilumab for the Management of Moderate-to-Severe Atopic Dermatitis in Pediatric Patients in Chile: A Series of 10 Clinical Cases]Ignacia Fuentes Escobar, Marie-Chantal Caussade, Cristóbal Lecaros Cornejo, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 14, 2010
Bronchial hyperreactivity to methacholine in atopic versus nonatopic asthmatic schoolchildren and preschoolersJose A Castro-Rodriguez, Pamela Navarrete-Contreras, Linus Holmgren, et al.
British Journal of Pharmacology|February 1, 1997
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferationA Virone-Oddos, V Desangle, D Provost, et al.
Archives of Dermatological Research|January 1, 1985
Normal peripheral-blood lymphocyte cAMP and cGMP resting levels in untreated patients with mycosis fungoidesA Aleksijevic, P Caussade, J M Lang, et al.
Pediatric Pulmonology|September 2, 2003
Risk factors for recurrent wheezing following acute bronchiolitis: a 12-month follow-upLorena Cifuentes, Solange Caussade, Claudia Villagrán, et al.
Journal of Neural Engineering|December 15, 2023
Towards a more accurate quasi-static approximation of the electric potential for neurostimulation with kilohertz-frequency sources<sup></sup>Thomas Caussade, Esteban Paduro, Matías Courdurier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998
Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?C Courteix, P Bourget, F Caussade, et al.
Pageof 9